Coronado Industries' 'PNT Update' Warmly Received at ASCRS Conference.Business Editors/Health/Medical Writers FOUNTAIN HILLS, Ariz.--(BUSINESS WIRE)--May 5, 2004 Coronado Industries Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: CDIK), the manufacturer of a unique, proprietary pneumatic device for the treatment of glaucoma, said today that the latest development of its technology had been presented to more than 20,000 of the nation's top ophthalmologists gathered at the American Society of Cataract and Refractive Surgery Refractive surgery A surgical procedure that corrects visual defects. Mentioned in: Photorefractive Keratectomy and Laser-Assisted In-Situ Keratomileusis refractive surgery Conference (ASCRS ASCRS American Society of Cataract and Refractive Surgery ASCRS American Society of Colon and Rectal Surgeons ) held in San Diego, May 1-4, to discuss the latest advancements in the field of ophthalmology. Coronado Industries, represented by medical directors Dr. Leo Leo, in astronomy Leo [Lat.,=the lion], northern constellation lying S of Ursa Major and on the ecliptic (apparent path of the sun through the heavens) between Cancer and Virgo; it is one of the constellations of the zodiac. Bores and Dr. John Li Vecchi, were very well received through a much acclaimed presentation and address given by Bores. The address reported on several aspects of Coronado Industries' cutting-edge, innovative PNT PNT Point PNT Paint (MacPaint graphic file format) PNT Patient PNT Pentagon (Washington, DC; US DoD) PNT Positioning, Navigation and Timing PNT Prime Number Theorem PNT Phenytoin technology and its applications. Bores, who is widely considered a leader in his field, has enjoyed a long and distinguished career, having received many awards for his work including the highly coveted cov·et v. cov·et·ed, cov·et·ing, cov·ets v.tr. 1. To feel blameworthy desire for (that which is another's). See Synonyms at envy. 2. To wish for longingly. See Synonyms at desire. Innovators in Ophthalmology Award presented to only a few by the ASCRS. He is perhaps best known as the co-inventor of Radial Keratotomy. Bores' address titled "PNT Update" was warmly received by an audience of his peers. He described the latest developments of Coronado's technology, which has been designed to bring relief to glaucoma sufferers around the world without the risk of invasive surgery. Coronado Industries has, in recent months, signed agreements with a number of leading distributors of ophthalmic equipment in Europe and has plans well in hand to market their technology in several other countries around the world. "We had several excellent conversations with a number of European distributors and were very much encouraged by their response," said Li Vecchi. The company has, for seven years, been dedicated to perfecting its patented Glaucoma Treatment Device. Through its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , Ophthalmic International, it focuses on the development of its patented procedure as a cost-effective alternative for the treatment of the most common types of glaucoma, which are open angle pigmentary. Please note: We shall be happy to send you a CD-ROM CD-ROM: see compact disc. CD-ROM in full compact disc read-only memory Type of computer storage medium that is read optically (e.g., by a laser). presentation of Bores' "PNT Update," which is available upon request to the following:
Contact: Bob Smith Victor Webb/Madlene Olson
Investor Relations Media
Coronado Industries Marston Webb International
480-837-6810 212-684-6601
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion